Literature DB >> 18390730

The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines.

Sheetal Sharma1, Nicole Kulk, Marcel F Nold, Ralph Gräf, Soo-Hyun Kim, Dietrich Reinhardt, Charles A Dinarello, Philip Bufler.   

Abstract

The IL-1 family member 7b (IL-1F7b) is a novel homolog of the IL-1 cytokine family discovered by computational cloning. We have reported that IL-1F7b shares critical amino acid residues with IL-18 and binds the IL-18-binding protein; in doing so, IL-1F7b augments the inhibition of IFN-gamma by the IL-18-binding protein. IL-1F7b also binds IL-18Ralpha but neither induces signal nor acts as a receptor antagonist. Hence, the function of IL-1F7b remains unknown. In the present study, we analyzed the intracellular expression pattern of IL-1F7b. Using two variants of GFP fusion constructs of human IL-1F7b stably expressed in RAW macrophages, only the postcleavage mature form of the IL-1F7b precursor-but not the N-terminal propiece-specifically translocates to the nucleus following LPS stimulation. IL-1F7b, like IL-1beta, IL-18, and IL-33, is processed by caspase-1 to generate the mature cytokines. Therefore, we tested whether caspase-1-mediated cleavage of the IL-1F7b precursor is required for mature IL-1F7b to translocate actively into the nucleus. Indeed, a specific caspase-1 inhibitor markedly reduced nuclear entry of IL-1F7b. In stable transfectants of human IL-1F7b in RAW macrophages stimulated with LPS, levels of TNF-alpha, IL-1alpha, IL-6, as well as the chemokine MIP-2, were substantially reduced (72-98%) compared with LPS-stimulated cells transfected with the empty plasmid. These results demonstrate that IL-1F7b translocates to the nucleus after caspase-1 processing and may act as a transcriptional modulator reducing the production of LPS-stimulated proinflammatory cytokines, consistent with IL-1F7b being an anti-inflammatory member of the IL-1 family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390730     DOI: 10.4049/jimmunol.180.8.5477

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  106 in total

1.  Behavioral and genetic investigations of low exploratory behavior in Il18r1(-/-) mice: we can't always blame it on the targeted gene.

Authors:  Amy F Eisener-Dorman; David A Lawrence; Valerie J Bolivar
Journal:  Brain Behav Immun       Date:  2010-05-23       Impact factor: 7.217

2.  Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells.

Authors:  Nozomu Sakai; Heather L Van Sweringen; Ritha M Belizaire; Ralph Cutler Quillin; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  J Gastroenterol Hepatol       Date:  2012-10       Impact factor: 4.029

3.  Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.

Authors:  Jesper F Højen; Thomas A Rasmussen; Karen Lise D Andersen; Anni A Winckelmann; Rune R Laursen; Jesper D Gunst; Holger J Møller; Mayumi Fujita; Lars Østergaard; Ole S Søgaard; Charles A Dinarello; Martin Tolstrup
Journal:  Mol Med       Date:  2015-04-14       Impact factor: 6.354

4.  Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells.

Authors:  Regina T Chustz; Deepti R Nagarkar; Julie A Poposki; Silvio Favoreto; Pedro C Avila; Robert P Schleimer; Atsushi Kato
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-24       Impact factor: 6.914

5.  The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1.

Authors:  Corinne Cayrol; Jean-Philippe Girard
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-13       Impact factor: 11.205

Review 6.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

7.  Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy.

Authors:  Lijuan Wang; Yanchun Quan; Yongfang Yue; Xueyuan Heng; Fengyuan Che
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

Review 8.  The IL-1 family: regulators of immunity.

Authors:  John E Sims; Dirk E Smith
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

9.  Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.

Authors:  Andreas Lingel; Thomas M Weiss; Marc Niebuhr; Borlan Pan; Brent A Appleton; Christian Wiesmann; J Fernando Bazan; Wayne J Fairbrother
Journal:  Structure       Date:  2009-10-14       Impact factor: 5.006

Review 10.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.